Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19

NCT04479202 is registered in ClinicalTrials.gov with Chinese Medical Association as lead sponsor.

NCT NCT04479202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04479202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19
Lead sponsor
Chinese Medical Association
Phase
Phase 4
Overall status
Completed
Start date
February 8, 2020
Completion date
April 23, 2020
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

berberine, covid-19